Unicycive Therapeutics (UNCY) Free Cash Flow Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - | 29.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.94% |
| Dec 31, 2025 | -22.25% |
| Sep 30, 2025 | 35.71% |
| Jun 30, 2025 | -32.92% |
| Mar 31, 2025 | -38.02% |
| Dec 31, 2024 | -48.01% |
| Sep 30, 2024 | -109.77% |
| Jun 30, 2024 | -15.21% |
| Mar 31, 2024 | -64.85% |
| Dec 31, 2023 | 27.04% |
| Sep 30, 2023 | -24.11% |
| Jun 30, 2023 | -80.57% |
| Mar 31, 2023 | -32.48% |
| Dec 31, 2022 | -333.64% |
| Sep 30, 2022 | -2.56% |
| Jun 30, 2022 | -1,304.15% |
| Mar 31, 2022 | -339.67% |
| Dec 31, 2021 | -160.78% |
| Sep 30, 2021 | -392.07% |